Trials / Completed
CompletedNCT01470053
Efficacy and Safety of Mometasone Furoate Plus Azelastine HCl Combination Versus Mometasone Furoate Alone or Azelastine Alone in Patients With Perennial Allergic Rhinitis
A Multicenter, Randomized, Double-blind Phase Ⅲ Study of Mometasone Furoate/Azelastine Hydrochloride Combination Group and Mometasone Furoate and Azelastine Hydrochloride Group 4 Weeks After Treatment, Each Treatment Group Comparisons for Evaluation of Efficacy and Safety in Perennial Allergic Rhinitis Patient.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 347 (actual)
- Sponsor
- Hanlim Pharm. Co., Ltd. · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate of efficacy and safety of mometasone furoate plus azelastine HCl in patients with perennial allergic rhinitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | mometasone furoate plus azelastine HCl | |
| DRUG | mometasone furoate | |
| DRUG | azelastine HCl |
Timeline
- Start date
- 2011-03-01
- Primary completion
- 2011-12-01
- Completion
- 2012-11-01
- First posted
- 2011-11-11
- Last updated
- 2013-08-27
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01470053. Inclusion in this directory is not an endorsement.